Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $7.8050 (3.38%) ($7.8050 - $7.8050) on Thu. Jun. 30, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.12% (three month average) | RSI | 67 | Latest Price | $7.8050(3.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.4% a day on average for past five trading days. | Weekly Trend | ATRA advances 16.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(32%) ARKK(31%) XLV(31%) IBB(30%) XAR(29%) | Factors Impacting ATRA price | ATRA will decline at least -3.06% in a week (0% probabilities). VXX(-74%) UNG(-26%) EDOC(-19%) USO(-18%) XOP(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.06% (StdDev 6.12%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.25(7.66%) | 10 Day Moving Average | $6.82(14.44%) | 20 Day Moving Average | $6.11(27.74%) | To recent high | -20.5% | To recent low | 66.4% | Market Cap | $580m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |